Mezzacapo v. Takeda Pharmaceuticals America, Inc. et al
Kailey Mezzacapo |
Takeda Pharmaceuticals America, Inc. d/b/a BioLife Plasma Services, Takeda Pharmaceuticals U.S.A., Inc. d/b/a BioLife Plasma Services, Takeda Pharmaceuticals America, Inc. doing business as BioLife Plasma Services, Takeda Pharmaceuticals U.S.A., Inc. doing business as BioLife Plasma Services and BioLife Plasma Services, L.P. |
1:2022cv01304 |
May 25, 2022 |
US District Court for the District of Colorado |
Scott T Varholak |
Personal Inj. Med. Malpractice |
28 U.S.C. § 1332 Diversity-Personal Injury |
Both |
Docket Report
This docket was last retrieved on July 13, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Filing 20 MINUTE ENTRY for Scheduling Conference held before Magistrate Judge Scott T. Varholak on 7/13/2022. Discovery due by 6/5/2023. Dispositive Motions due by 9/2/2023. Final Pretrial Conference set for 11/8/2023 09:30 AM in Courtroom A 402 before Magistrate Judge Scott T. Varholak. FTR: 402. (morti, ) |
Filing 19 Proposed Scheduling Order by Defendant BioLife Plasma Services, L.P.. (Taylor, Jacob) |
![]() |
Filing 17 CONSENT to Jurisdiction of Magistrate Judge by Defendant BioLife Plasma Services, L.P. All parties consent.. (Taylor, Jacob) |
Filing 16 ANSWER to #15 Amended Complaint by BioLife Plasma Services, L.P..(Taylor, Jacob) |
Filing 15 PLAINTIFF'S FIRST AMENDED COMPLAINT AND JURY DEMAND against BioLife Plasma Services, L.P., filed by Kailey Mezzacapo. (Entered pursuant to ECF 14)(cmadr, ) |
![]() |
Filing 13 NOTICE of Entry of Appearance of James H. Chalat by James H. Chalat on behalf of All Plaintiffs Attorney James H. Chalat added to party Kailey Mezzacapo(pty:pla) (Chalat, James) |
Filing 12 NOTICE of Filing Amended Pleading re #6 Amended Complaint by Plaintiff Kailey Mezzacapo (Attachments: #1 Proposed Document District Court Plaintiff's First Amended Complaint and Jury Demand, #2 Proposed Document Plaintiff's First Amended Complaint and Jury Demand)(Hatten, Russell) |
Filing 11 NOTICE of Entry of Appearance by Michele On-Ja Choe on behalf of Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. Attorney Michele On-Ja Choe added to party Takeda Pharmaceuticals America, Inc.(pty:dft), Attorney Michele On-Ja Choe added to party Takeda Pharmaceuticals U.S.A., Inc. (pty:dft) (Choe, Michele) |
Filing 10 NOTICE of Entry of Appearance of Russell R. Hatten by Russell Ray Hatten on behalf of All Plaintiffs Attorney Russell Ray Hatten added to party Kailey Mezzacapo(pty:pla) (Hatten, Russell) |
![]() |
Filing 8 Magistrate Judge consent form issued pursuant to D.C.COLO.LCivR 40.1, direct assignment of civil actions to full time magistrate judges. (sapod, ) Modified on 5/31/2022 to correct text (sapod, ). |
Filing 7 RETURN of Service of Summons, Complaint and Jury Demand upon Defendant/Respondent on 4/25/2022 (sapod, ) Modified on 5/26/2022 to correct text and to correct PDF (sapod, ). |
Filing 6 Complaint and Jury Demand against Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc., filed by Kailey Mezzacapo.(sapod, ) Modified to correct PDF on 5/26/2022 (sapod, ). |
Filing 5 FIRST AND FINAL NOTICE TO ALL ATTORNEY(S) AND UNREPRESENTED PARTIES IN REMOVED, TRANSFERRED, OR OTHER CASES. To receive any further notice in a case removed or transferred to this court, or special matters including discovery disputes, bankruptcy appeals, or withdrawals of reference, Multi-district litigation (MDL), etc., all attorneys and unrepresented parties must enter an appearance under D.C.COLO.LAttyR 5(a). An attorney must be an active member of this court's bar and be in good standing in accordance with D.C.COLO.LAttyR 3. A waiver of the fee for bar admission may apply in limited situations. (Text Only Entry) (sapod, ) |
Filing 4 Case assigned to Magistrate Judge Scott T. Varholak. Text Only Entry. (sapod, ) |
Filing 3 ANSWER to Complaint by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc..(Taylor, Jacob) |
Filing 2 CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Takeda Pharmaceuticals Company Limited for Takeda Pharmaceuticals U.S.A., Inc. ; Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.. (Taylor, Jacob) |
Filing 1 NOTICE OF REMOVAL by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. from District Court of Boulder County, Colorado, Case Number 2022CV30239. (Filing fee $ 402, Receipt Number ACODC-8476440), filed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc.. (Attachments: #1 Exhibit A - Mezzacapo Complaint, #2 Exhibit B - Return of Service, #3 Exhibit C - Redacted Colorado Secretary of State, #4 Exhibit D - Civil Case Cover Sheet, #5 Exhibit E - State Court Docket and Filings, #6 Civil Cover Sheet)(Taylor, Jacob) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Colorado District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.